Download PDF
Int J Angiol 2016; 25(05): e81-e83
DOI: 10.1055/s-0035-1551795
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hereditary Hemorrhagic Telangiectasia and Myocardial Infarction

Efrén Martínez-Quintana
2   Ophthalmology Service, Dr Negrín University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain
,
Fayna Rodríguez-González
2   Ophthalmology Service, Dr Negrín University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain
,
Silvia Gopar-Gopar
1   Cardiology Service, Insular-Materno Infantil University Hospital, Las Palmas de Gran Canaria, Spain
› Author Affiliations
Further Information

Publication History

Publication Date:
18 May 2015 (online)

    Permissions and Reprints

Abstract

Hereditary hemorrhagic telangiectasia, also known as Osler–Weber–Rendu syndrome, is an autosomal dominant genetic disorder that leads to epistaxis, gastrointestinal bleeding, iron deficiency anemia, and arteriovenous malformations at the lungs, the liver, and the brain. However, due to its rarity and its unspecific findings on routine examinations, diagnosis is not easy unless suspected due to hypoxemia or paradoxical embolism. We present a case of a 46-year-old-woman with hereditary hemorrhagic telangiectasia and hypoxemia who presented a myocardial infarction secondary to paradoxical embolism through pulmonary arteriovenous malformations.

Keywords

hereditary hemorrhagic telangiectasia - Osler–Weber–Rendu syndrome - pulmonary arteriovenous malformations - myocardial infarction

Note

The authors hereby confirm that neither the manuscript nor any part of it has been published or is being considered for publication elsewhere. We attest to the fact that all authors have contributed significantly to the work, have read the manuscript, and attest to the validity and legitimacy of the data and its interpretation. The authors have also certified that they comply with the principles of ethical publishing. No author has conflict of interest.


 

  • References

  • 1 Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998; 158 (2) 643-661
    CrossrefPubMedGoogle Scholar
  • 2 Sharifah AI, Jasvinder K, Rus AA. Pulmonary arteriovenous malformation: a rare cause of cyanosis in a child. Singapore Med J 2009; 50 (4) e127-e129
    PubMedGoogle Scholar
  • 3 Meek ME, Meek JC, Beheshti MV. Management of pulmonary arteriovenous malformations. Semin Intervent Radiol 2011; 28 (1) 24-31
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Khalil A, Farres MT, Mangiapan G, Tassart M, Bigot JM, Carette MF. Pulmonary arteriovenous malformations. Chest 2000; 117 (5) 1399-1403
    CrossrefPubMedGoogle Scholar
  • 5 Andersen PE, Kjeldsen AD. Clinical and radiological long-term follow-up after embolization of pulmonary arteriovenous malformations. Cardiovasc Intervent Radiol 2006; 29 (1) 70-74
    CrossrefPubMedGoogle Scholar
  • 6 Faughnan ME, Palda VA, Garcia-Tsao G , et al; HHT Foundation International - Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011; 48 (2) 73-87
    CrossrefPubMedGoogle Scholar
  • 7 Trerotola SO, Pyeritz RE. PAVM embolization: an update. AJR Am J Roentgenol 2010; 195 (4) 837-845
    CrossrefPubMedGoogle Scholar